Abstract: The present invention describes a pharmaceutical preparation in which a reactive chlorine-oxygen compound is provided in the form of a medicament inhalable into the lungs.

Abstract: The present invention describes a pharmaceutical preparation for use in the treatment of systemic inflammatory response syndrome (SIRS).

Abstract: The invention relates to a pharmaceutically active substance comprising at least one peptide portion having the amino acid sequences m-v-v-y-f-r (first peptide portion), characterised in that the pharmaceutically active substance comprises at least additional one amino acid and/or peptide portion at the N-terminal end and/or at the C-terminal end of the first peptide portion (second peptide portion and/or third peptide portion) being directly bound to the peptide portion having the amino acid sequences m-v-v-y-f-r (first peptide portion). The invention further relates to a pharmaceutical composition and a drug for the treatment of cancer.

Abstract: A device for providing a skin or wound dressing, a wound treatment set, and a method to provide a skin or wound dressing, wherein the skin or wound dressing includes an active substance, and wherein the device comprises at least two chambers for the storage of at least two liquids, which are openable by mechanical action, so that, after opening of the chambers, the liquids are miscible and are transferrable to an active substance carrier.

Abstract: A method for the isolation of specific molecules which bind highly selectively to chosen target molecules. In particular, due to displacement with a specific competitor, binding molecules are selected which preferably bind to previously known epitopes.

Abstract: The invention relates to the use of dichloric acids and the derivatives thereof for producing medicaments used for disinfecting body cavities.